Jesús Rodríguez-Pascual

715 total citations
28 papers, 550 citations indexed

About

Jesús Rodríguez-Pascual is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jesús Rodríguez-Pascual has authored 28 papers receiving a total of 550 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 10 papers in Surgery and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jesús Rodríguez-Pascual's work include Colorectal Cancer Treatments and Studies (8 papers), Pancreatic and Hepatic Oncology Research (8 papers) and Cancer Genomics and Diagnostics (7 papers). Jesús Rodríguez-Pascual is often cited by papers focused on Colorectal Cancer Treatments and Studies (8 papers), Pancreatic and Hepatic Oncology Research (8 papers) and Cancer Genomics and Diagnostics (7 papers). Jesús Rodríguez-Pascual collaborates with scholars based in Spain, United States and Mexico. Jesús Rodríguez-Pascual's co-authors include Antonio Cubillo, Manuel Hidalgo, Fernando López‐Ríos, Yolanda Quijano, Rafael Álvarez, Pedro P. López‐Casas, Carlos Plaza, E. Vicente, Elena García-García and Susana Tabernero and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and British Journal of Cancer.

In The Last Decade

Jesús Rodríguez-Pascual

27 papers receiving 543 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jesús Rodríguez-Pascual Spain 10 404 143 137 125 111 28 550
Gro Linno Willemoe Denmark 11 249 0.6× 114 0.8× 80 0.6× 58 0.5× 73 0.7× 38 413
C.J.A. Punt Netherlands 11 299 0.7× 75 0.5× 99 0.7× 216 1.7× 88 0.8× 26 624
Hirotsugu Notsuda Japan 13 223 0.6× 92 0.6× 144 1.1× 196 1.6× 122 1.1× 49 537
Marie Alt France 11 543 1.3× 160 1.1× 119 0.9× 256 2.0× 123 1.1× 20 748
Marcello Ferretti Fanelli Brazil 16 410 1.0× 239 1.7× 80 0.6× 305 2.4× 119 1.1× 47 697
Mitsuhiko Iwamoto Japan 11 258 0.6× 101 0.7× 136 1.0× 132 1.1× 80 0.7× 42 540
Annemie Rutten Belgium 11 451 1.1× 215 1.5× 75 0.5× 246 2.0× 150 1.4× 29 693
Shona Hendry Australia 12 462 1.1× 110 0.8× 88 0.6× 226 1.8× 92 0.8× 22 614
Thomas Armstrong United Kingdom 10 423 1.0× 75 0.5× 195 1.4× 133 1.1× 95 0.9× 22 694
Thaïs Baert Belgium 16 400 1.0× 102 0.7× 189 1.4× 86 0.7× 149 1.3× 47 955

Countries citing papers authored by Jesús Rodríguez-Pascual

Since Specialization
Citations

This map shows the geographic impact of Jesús Rodríguez-Pascual's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jesús Rodríguez-Pascual with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jesús Rodríguez-Pascual more than expected).

Fields of papers citing papers by Jesús Rodríguez-Pascual

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jesús Rodríguez-Pascual. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jesús Rodríguez-Pascual. The network helps show where Jesús Rodríguez-Pascual may publish in the future.

Co-authorship network of co-authors of Jesús Rodríguez-Pascual

This figure shows the co-authorship network connecting the top 25 collaborators of Jesús Rodríguez-Pascual. A scholar is included among the top collaborators of Jesús Rodríguez-Pascual based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jesús Rodríguez-Pascual. Jesús Rodríguez-Pascual is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rodríguez-Pascual, Jesús, et al.. (2025). Durvalumab (DUR) effectiveness in advanced biliary tract cancer (aBTC) patients based on real-world data evidence.. Journal of Clinical Oncology. 43(4_suppl). 598–598.
2.
Düzağaç, Fahriye, Nan Deng, Laura Reyes-Uribe, et al.. (2024). Genomic Landscape of Lynch Syndrome Colorectal Neoplasia Identifies Shared Mutated Neoantigens for Immunoprevention. Gastroenterology. 166(5). 787–801.e11. 17 indexed citations
3.
Zafra, Olga, Javier Sierra, Diana Simón, et al.. (2023). Dichotomous colorectal cancer behaviour. Critical Reviews in Oncology/Hematology. 189. 104067–104067. 8 indexed citations
4.
Rodríguez-Pascual, Jesús, Benedetto Ielpo, Mercedes López, et al.. (2022). Watch-and-Wait policy versus robotic surgery for locally advanced rectal cancer: A cost-effectiveness study (RECCOSTE). Surgical Oncology. 41. 101710–101710. 7 indexed citations
5.
Madurga, Rodrigo, et al.. (2021). Hemogram-derived ratios as prognostic markers of ICU admission in COVID-19. BMC Emergency Medicine. 21(1). 89–89. 24 indexed citations
6.
7.
Rodríguez-Pascual, Jesús, Ángel Ayuso‐Sacido, & Cristóbal Belda-Iniesta. (2019). Drug resistance in cancer immunotherapy: new strategies to improve checkpoint inhibitor therapies. PubMed. 2(4). 980–993. 16 indexed citations
8.
Rodríguez-Pascual, Jesús & Antonio Cubillo. (2017). Dynamic Biomarkers of Response to Antiangiogenic Therapies in Colorectal Cancer: A Review. Current pharmacogenomics and personalized medicine (Online). 15(2). 81–85. 9 indexed citations
9.
Rodríguez-Pascual, Jesús. (2016). Massive Intrabile Duct Invasion Caused by a Fatal Progression of Colonic Adenocarcinoma: Abdominal Computed Tomography Findings and Cholangiography Correlation. JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH. 10(4). XD04–XD05. 1 indexed citations
10.
Rodríguez-Pascual, Jesús, Elena Garralda, Estela Vega, et al.. (2016). ERCC-1 as a predictive biomarker for radioresistance in resected pancreatic cancer undergoing perioperative radiotherapy.. Journal of Clinical Oncology. 34(15_suppl). e15714–e15714. 1 indexed citations
11.
Cubillo, Antonio, Manuel Muñoz, Gregory R. Pond, et al.. (2016). Dynamic angiogenic switch as predictor of response to chemotherapy+ bevacizumab in patients with metastatic colorectal cancer.. Journal of Clinical Oncology. 34(15_suppl). e15126–e15126. 2 indexed citations
12.
Toledo, Rodrigo A., Antonio Cubillo, Estela Vega, et al.. (2016). Clinical validation of prospective liquid biopsy monitoring in patients with wild-type RAS metastatic colorectal cancer treated with FOLFIRI-cetuximab. Oncotarget. 8(21). 35289–35300. 46 indexed citations
13.
Álvarez, Rafael, Mónica Musteanu, Elena García-García, et al.. (2013). Stromal disrupting effects of nab-paclitaxel in pancreatic cancer. British Journal of Cancer. 109(4). 926–933. 237 indexed citations
14.
Rodríguez-Pascual, Jesús, Elena García-García, N.V. Rajeshkumar, et al.. (2012). A preclinical and clinical study of mycophenolate mofetil in pancreatic cancer. Investigational New Drugs. 31(1). 14–19. 24 indexed citations
15.
Cubillo, Antonio, Elena García‐García, Jesús Rodríguez-Pascual, et al.. (2012). A Prospective Pilot Study of Target-guided Personalized Chemotherapy with Intensity-modulated Radiotherapy in Patients With Early Rectal Cancer. American Journal of Clinical Oncology. 37(2). 117–121. 23 indexed citations
16.
Durán, Ignacio, Clara Montagut, Emiliano Calvo, et al.. (2012). Overcoming docetaxel resistance in advanced castration-resistant prostate cancer (CRPC): A phase I/II trial of the combination of temsirolimus and docetaxel.. Journal of Clinical Oncology. 30(5_suppl). 250–250. 2 indexed citations
17.
Cubillo, Antonio, Jesús Rodríguez-Pascual, Yolanda Quijano, et al.. (2012). Antitumor activity of  nab-paclitaxel and gemcitabine in resectable pancreatic cancer.. Journal of Clinical Oncology. 30(15_suppl). 4040–4040. 8 indexed citations
18.
Rodríguez-Pascual, Jesús, Elaine Cheng, Pablo Maroto, & Ignacio Durán. (2010). Emergent toxicities associated with the use of mTOR inhibitors in patients with advanced renal carcinoma. Anti-Cancer Drugs. 21(5). 478–486. 45 indexed citations
19.
Rodríguez-Pascual, Jesús, et al.. (2009). Isolated recurrence of distal adenocarcinoma of the extrahepatic bile duct on a draining sinus scar after curative resection: Case Report and review of the literature. World Journal of Surgical Oncology. 7(1). 96–96. 2 indexed citations
20.
Rodríguez-Pascual, Jesús, Fernando López‐Ríos, Antonio Cubillo, et al.. (2009). Use of combined biomarkers analysis to predict response to chemotherapy in colorectal cancer: A single-institution feasibility study. Journal of Clinical Oncology. 27(15_suppl). 11074–11074. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gro Linno Willemoe Breakdown of academic impact, for papers by C.J.A. Punt Breakdown of academic impact, for papers by Hirotsugu Notsuda Breakdown of academic impact, for papers by Marie Alt Breakdown of academic impact, for papers by Marcello Ferretti Fanelli Breakdown of academic impact, for papers by Mitsuhiko Iwamoto Breakdown of academic impact, for papers by Annemie Rutten Breakdown of academic impact, for papers by Shona Hendry Breakdown of academic impact, for papers by Thomas Armstrong Breakdown of academic impact, for papers by Thaïs Baert
Rankless by CCL
2026